Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 12 Sep 24 EFFECT Notice of effectiveness
- 5 Sep 24 S-1/A IPO registration (amended)
- 23 Aug 24 S-1/A IPO registration (amended)
- 8 Aug 24 S-1/A IPO registration (amended)
- 1 Jul 24 S-1/A IPO registration (amended)
- 2 Feb 24 S-1/A IPO registration (amended)
- 12 Dec 23 S-1/A IPO registration (amended)
- 28 Aug 23 S-1/A IPO registration (amended)
- 17 Jul 23 S-1/A IPO registration (amended)
- 29 Jun 23 S-1/A IPO registration (amended)
- 2 Jun 23 S-1/A IPO registration (amended)
- 8 May 23 S-1/A IPO registration (amended)
-
3 Nov 22 S-1/A IPO registration (amended)
- 9 Sep 22 S-1 IPO registration
VTRO similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the inclusion in this Registration Statement on Form S-1 (Amendment No. 1) of our report dated April 26, 2022, except for Note 1 which is dated November 3, 2022 with respect to the audited financial statements of Vitro Biopharma Inc. for the years ended October 31, 2021 and 2020. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
We also consent to the references to us under the heading “Experts” in such Registration Statement.
/s/ MaloneBailey, LLP
www.malonebailey.com
Houston, Texas
November 3, 2022